Cole Wayant

1.4k total citations
67 papers, 903 citations indexed

About

Cole Wayant is a scholar working on Statistics, Probability and Uncertainty, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cole Wayant has authored 67 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Statistics, Probability and Uncertainty, 28 papers in Economics and Econometrics and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cole Wayant's work include Meta-analysis and systematic reviews (40 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and Clinical practice guidelines implementation (15 papers). Cole Wayant is often cited by papers focused on Meta-analysis and systematic reviews (40 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and Clinical practice guidelines implementation (15 papers). Cole Wayant collaborates with scholars based in United States, Canada and United Kingdom. Cole Wayant's co-authors include Matt Vassar, Chase Meyer, Jared Scott, Jake X. Checketts, Herman Aguinis, Mousumi Som, Erick H. Turner, Andrew Ross, Tanja Rombey and Peter J. Gill and has published in prestigious journals such as JAMA, PLoS ONE and CHEST Journal.

In The Last Decade

Cole Wayant

66 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cole Wayant United States 19 457 288 231 151 120 67 903
Nicholas DeVito United Kingdom 12 217 0.5× 264 0.9× 181 0.8× 80 0.5× 92 0.8× 33 661
Amélie Yavchitz France 14 352 0.8× 135 0.5× 128 0.6× 39 0.3× 120 1.0× 32 973
lain Chalmers United Kingdom 8 369 0.8× 245 0.9× 174 0.8× 92 0.6× 175 1.5× 9 809
Martin Van Der Weyden United States 3 292 0.6× 381 1.3× 115 0.5× 168 1.1× 205 1.7× 5 1.0k
Julia Kreis Germany 11 147 0.3× 158 0.5× 152 0.7× 62 0.4× 161 1.3× 15 760
John P. A. Ioannidis United States 5 290 0.6× 168 0.6× 142 0.6× 54 0.4× 90 0.8× 5 626
Ignacio Atal France 11 205 0.4× 115 0.4× 154 0.7× 21 0.1× 57 0.5× 20 516
Emma K. Reid Canada 6 338 0.7× 104 0.4× 67 0.3× 11 0.1× 144 1.2× 9 543
Tanja Rombey Germany 16 231 0.5× 118 0.4× 77 0.3× 8 0.1× 138 1.1× 44 786
Bruce P. Squires United States 8 113 0.2× 121 0.4× 60 0.3× 41 0.3× 102 0.8× 38 438

Countries citing papers authored by Cole Wayant

Since Specialization
Citations

This map shows the geographic impact of Cole Wayant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cole Wayant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cole Wayant more than expected).

Fields of papers citing papers by Cole Wayant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cole Wayant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cole Wayant. The network helps show where Cole Wayant may publish in the future.

Co-authorship network of co-authors of Cole Wayant

This figure shows the co-authorship network connecting the top 25 collaborators of Cole Wayant. A scholar is included among the top collaborators of Cole Wayant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cole Wayant. Cole Wayant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wayant, Cole, et al.. (2023). Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials. JCO Oncology Practice. 19(11). 1048–1052. 3 indexed citations
2.
Wayant, Cole, Natalie C. Kerr, Andrea C. Tricco, et al.. (2021). Identification of Evidence for Key Positive Psychological Constructs in Pediatric and Adolescent/Young Adult Patients with Cancer: A Scoping Review. Journal of Adolescent and Young Adult Oncology. 10(3). 247–259. 10 indexed citations
3.
Wayant, Cole, et al.. (2021). A Reliability Generalization Meta-Analysis of 17 Patient-Reported Outcome Measures for Positive Psychosocial Constructs in Children, Adolescents, and Young Adults with Cancer. Journal of Adolescent and Young Adult Oncology. 11(2). 163–172. 4 indexed citations
4.
Wayant, Cole, et al.. (2021). STARD Adherence in an Interventional Radiology Guideline for Diagnostic Arteriography. Clinical Medicine & Research. 19(1). 26–31. 2 indexed citations
5.
6.
7.
Buss, Lewis, et al.. (2020). Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018. PLoS ONE. 15(7). e0236345–e0236345. 15 indexed citations
8.
Wayant, Cole, Lisa Cosgrove, Elie A. Akl, et al.. (2020). Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform. BMJ evidence-based medicine. 27(1). 46–54. 20 indexed citations
9.
Wayant, Cole, et al.. (2020). Risk of Bias and Quality of Reporting in Colon and Rectal Cancer Systematic Reviews Cited by National Comprehensive Cancer Network Guidelines. Journal of General Internal Medicine. 35(8). 2352–2356. 10 indexed citations
10.
11.
Vassar, Matt, et al.. (2019). Evaluation of selective outcome reporting and trial registration practices among addiction clinical trials. Addiction. 115(6). 1172–1179. 15 indexed citations
12.
Scott, Jared, et al.. (2019). An Evaluation of Publication Bias in High-Impact Orthopaedic Literature. JBJS Open Access. 4(2). e0055–e0055. 15 indexed citations
13.
Wayant, Cole, et al.. (2019). Do oncology researchers adhere to reproducible and transparent principles? A cross-sectional survey of published oncology literature. BMJ Open. 9(12). e033962–e033962. 15 indexed citations
14.
Vassar, Matt, et al.. (2019). Using the CONSORT statement to evaluate the completeness of reporting of addiction randomised trials: a cross-sectional review. BMJ Open. 9(9). e032024–e032024. 17 indexed citations
15.
Wayant, Cole. (2019). Noninferiority Trials - Oncology. OSF Preprints (OSF Preprints). 1 indexed citations
16.
Wayant, Cole, et al.. (2019). Evaluation of the NCCN guidelines using the RIGHT Statement and AGREE-II instrument: a cross-sectional review. BMJ evidence-based medicine. 24(6). 219–226. 20 indexed citations
17.
Ross, Andrew, et al.. (2018). Evaluation of spin in the abstracts of otolaryngology randomized controlled trials. The Laryngoscope. 129(9). 2036–2040. 44 indexed citations
18.
Wayant, Cole. (2018). Central protocol for assessing spin in the biomedical literature.. OSF Preprints (OSF Preprints). 5 indexed citations
19.
Wayant, Cole & Matt Vassar. (2018). A comparison of matched interim analysis publications and final analysis publications in oncology clinical trials. Annals of Oncology. 29(12). 2384–2390. 9 indexed citations
20.
Wayant, Cole, et al.. (2017). Evidence of selective reporting bias in hematology journals: A systematic review. PLoS ONE. 12(6). e0178379–e0178379. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas DeVito Breakdown of academic impact, for papers by Amélie Yavchitz Breakdown of academic impact, for papers by lain Chalmers Breakdown of academic impact, for papers by Martin Van Der Weyden Breakdown of academic impact, for papers by Julia Kreis Breakdown of academic impact, for papers by John P. A. Ioannidis Breakdown of academic impact, for papers by Ignacio Atal Breakdown of academic impact, for papers by Emma K. Reid Breakdown of academic impact, for papers by Tanja Rombey Breakdown of academic impact, for papers by Bruce P. Squires
Rankless by CCL
2026